Skip to main content
Explore URMC

Kristen M. O'Dwyer, M.D.


Showing all 16 journal articles & 0 books available

Journal Articles

Ho TC, LaMere M, Stevens BM, Ashton JM, Myers JR, O'Dwyer KM, Liesveld JL, Mendler JH, Guzman M, Morrissette JD, Zhao J, Wang ES, Wetzler M, Jordan CT, Becker MW. "Evolution of acute myelogenous leukemia stem cell properties after treatment and progression." Blood.. 2016 Sep 29; 128(13):1671-8. Epub 2016 Jul 15.

Tyagi V, Alwaseem H, O'Dwyer KM, Ponder J, Li QY, Jordan CT, Fasan R. "Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs." Bioorganic & medicinal chemistry.. 2016 Sep 1; 24(17):3876-3886. Epub 2016 Jun 16.

O'Dwyer KM, Advani AS. "When to Treat Adults Like Children: Optimizing Therapy for Lymphoblastic Lymphoma in Young Adults." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 Feb 20; 34(6):533-8. Epub 2015 Dec 23.

Bennett, JM; Dsouza, KG; Patel, M; O'Dwyer KM. "Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report." Leukemia research reports. 2015; 4(1): 12-4.

Kolev JN, O'Dwyer KM, Jordan CT, Fasan R. "Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization." ACS chemical biology.. 2014 Jan 17; 9(1):164-73. Epub 2013 Nov 08.

Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikharuddin JJ, Mulford D, Chen R, Bechelli J, Rosell K, Minhajuddin M, Jordan CT, Phillips GL. "A phase I study of decitabine and rapamycin in relapsed/refractory AML." Leukemia research.. 2013 Dec; 37(12):1622-7. Epub 2013 Sep 08.

Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, O'Dwyer KM, Li Z, Shi L, Greninger P, Settleman J, Benes C, Hagen FK, Munger J, Crooks PA, Becker MW, Jordan CT. "Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells." The Journal of biological chemistry.. 2013 Nov 22; 288(47):33542-58. Epub 2013 Oct 02.

Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O'Dwyer KM, Liesveld JL, Brookes PS, Becker MW, Jordan CT. "BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells." Cell stem cell.. 2013 Mar 7; 12(3):329-41. Epub 2013 Jan 17.

O'Dwyer K, Maslak P. "Azacitidine and the beginnings of therapeutic epigenetic modulation." Expert opinion on pharmacotherapy.. 2008 Aug; 9(11):1981-6.

Gruvberger-Saal SK, Cunliffe HE, Carr KM, Hedenfalk IA. "Microarrays in breast cancer research and clinical practice--the future lies ahead." Endocrine-related cancer.. 2006 Dec; 13(4):1017-31.

Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, Wagner U, Kallioniemi OP, Trent JM, Morin PJ, Meltzer PS. "Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome." Oncogene.. 2004 Mar 18; 23(12):2264-74.

Carr KM, Rosenblatt K, Petricoin EF, Liotta LA. "Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy." Human genomics.. 2004 Jan; 1(2):134-40.

Carr KM, Bittner M, Trent JM. "Gene-expression profiling in human cutaneous melanoma." Oncogene.. 2003 May 19; 22(20):3076-80.

Thomas, RS; Rank, DR; Jovanovich, S; Hogenesch, JB; Zastro, GM; Carr, KM; Bradfield, CA. "Early results from a dioxin genome project." Toxicologist. 1999; : 307.

Luo, G; Gu, Y; Jain, S; Chan, WK; Carr, KM; Hogenesch, JB; Zastro, GM; Carr, KM; Bradfield, CA. "Molecular characterization of the murine HIF-1 alpha locus." Gene Expressions. 1997; : 287-99.

Chien,AJ; Carr, KM; Shirokov, RE; Rios, E; Hosey, MM. "Identification of palmitoylation sites within the L-type calcium channel beta-two subunit and effects on channel function." Journal of Biological Chemistry. 1996; : 26465-68.